Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.
Naruhiko IkomaJanice N CormierBarry W FeigXianglin L DuJose-Miguel YamalWayne HofstetterPrajnan DasJaffer A AjaniChristina L RolandKeith FournierRichard RoyalPaul MansfieldBrian D BadgwellPublished in: Cancer (2018)
Racial/ethnic disparities in the use of preoperative chemotherapy and in outcomes exist among patients with gastric cancer in the United States. Efforts to improve the access to high-quality cancer care in minority groups may reduce racial disparities in gastric cancer in the United States. Cancer 2018;124:998-1007. © 2018 American Cancer Society.
Keyphrases
- papillary thyroid
- end stage renal disease
- squamous cell
- patients undergoing
- ejection fraction
- chronic kidney disease
- locally advanced
- newly diagnosed
- affordable care act
- lymph node metastasis
- prognostic factors
- electronic health record
- african american
- type diabetes
- big data
- healthcare
- squamous cell carcinoma
- radiation therapy
- quality improvement
- adipose tissue
- rectal cancer
- weight loss